Compounds > dactinomycin

dactinomycin and Bacterial Infections, Gram-Negative

dactinomycin has been researched along with Bacterial Infections, Gram-Negative in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, KJ; Lei, HY; Lin, YS; Wang, SD1
Ammons, WS; Grinna, L; Horwitz, A; Kohn, FR; Kung, AH; Theofan, G; Weickmann, J1
Akiyama, K; Hiramatsu, N; Igari, J; Koyama, T; Oguri, T1

Other Studies

3 other study(ies) available for dactinomycin and Bacterial Infections, Gram-Negative

ArticleYear
Sepsis-induced apoptosis of the thymocytes in mice.
    Journal of immunology (Baltimore, Md. : 1950), 1994, May-15, Volume: 152, Issue:10

    Topics: Animals; Apoptosis; Atrophy; Cycloheximide; Dactinomycin; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Mice; Mice, Inbred C3H; T-Lymphocytes; Thymus Gland; Tumor Necrosis Factor-alpha

1994
Protective effect of a recombinant amino-terminal fragment of bactericidal/permeability-increasing protein in experimental endotoxemia.
    The Journal of infectious diseases, 1993, Volume: 168, Issue:5

    Topics: Animals; Antimicrobial Cationic Peptides; Blood Proteins; Dactinomycin; Gram-Negative Bacterial Infections; Interleukin-1; Lipopolysaccharides; Male; Membrane Proteins; Mice; Mice, Inbred Strains; Peptide Fragments; Recombinant Proteins; Shock, Septic; Tumor Necrosis Factor-alpha

1993
[Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].
    The Japanese journal of antibiotics, 2003, Volume: 56, Issue:5

    Topics: Carbapenems; Cefozopran; Cephalosporins; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Monobactams; Penicillins; Product Surveillance, Postmarketing; Time Factors

2003